🔎 Trials Near Me

Akèy › Obèsite › Kalifòni › San Diego

Etid klinik pou Obèsite nan San Diego, CA

23 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Artemis Institute for Clinical Research, San Diego
  • Apex Clinical Research, San Diego
Laj 18 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07684235

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Acclaim Clinical Research, San Diego
Laj 45 a 99 · Tout sèks · Mizajou Oct 5, 2026 · NCT07037433

Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity

Ap rekriteVolontè an sante akeyi
  • San Diego State University, San Diego
Laj 18 a 64 · Tout sèks · Mizajou Oct 5, 2026 · NCT05726942

Efficacy of Using Mobile Health Applications for Health

Ap rekriteVolontè an sante akeyi
  • San Diego State University, San Diego
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT05589155

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

Ap rekriteVolontè an sante akeyi
  • San Diego State University, San Diego
Laj 18 a 64 · Tout sèks · Mizajou Oct 2, 2026 · NCT05279729

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • Artemis Insitute for Clin Res, San Diego
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Artemis Institute for Clinical Research, San Diego
  • Scripps Whittier Diabetes Institute, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • San Diego Cardiac Center, San Diego
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being

Ap rekrite
  • San Diego State University, San Diego
  • UC San Diego Health, San Diego
Laj 18 ak plis · Fanm · Mizajou Sep 15, 2026 · NCT07792837

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Artemis Institute for Clinical Research, LLC, San Diego
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, San Diego
  • ACCOMPLISH-2 Research Site, La Jolla · 11 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Effects of Watermelon or Low-fat Cookie Consumption on Wellness

Ap rekriteVolontè an sante akeyi
  • School of Exercise and Nutritional Sciences, San Diego
Laj 18 a 50 · Tout sèks · Mizajou Aug 28, 2026 · NCT06323070

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • G&J Research, San Diego
  • San Diego Veterans Affairs, San Diego
  • Scripps Memorial Hospital La Jolla, La Jolla · 11 mi lwen
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, San Diego
  • ACCOMPLISH-1 Research Site, La Jolla · 11 mi lwen
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)

Ap rekrite
  • University of California, San Diego, San Diego
Laj 18 a 65 · Tout sèks · Mizajou Jul 14, 2026 · NCT06783751

Time-restricted Eating and Healthy Eating in Patients With Metabolic Liver Disease or Cancer

Ap rekrite
  • University of California San Diego, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 25, 2026 · NCT06824974

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Ap rekriteFaz 3Volontè an sante akeyi
  • Vanda Investigational Site, San Diego
Laj 18 a 65 · Tout sèks · Mizajou Apr 20, 2026 · NCT07446439

Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes

Ap rekrite
  • UCSD Center for Healthy Eating and Activity Research (CHEAR, La Jolla · 11 mi lwen
Laj 18 a 55 · Fanm · Mizajou Mar 17, 2026 · NCT07478263

Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers

Ap rekrite
  • University of California San Diego Altman Clinical and Translational Research Institute, La Jolla · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Dec 17, 2025 · NCT06891352

Research Framework Exploring Sleep Health

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Scripps Research Institute, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 28, 2024 · NCT05197738

Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients

Ap rekriteFaz 2
  • University of California San Diego, La Jolla · 11 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou May 16, 2023 · NCT04721873

Etid Obèsite nan lòt vil

Lòt etid nan San Diego

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.